Cardiovalve Transfemoral Mitral Valve System
NCT: NCT03813524 · TERMINATED
Brief Summary
This study is to evaluate the safety and technical performance of the Cardiovalve Transfemoral Mitral Valve System with its associated procedure, to minimize mitral regurgitation. Data collected in this clinical study will include 30-day safety and performance of the device and delivery system, and long-term clinical outcomes over a follow-up of 5 years.
Frequently Asked Questions
What is Cardiovalve Transfemoral Mitral Valve System?
Cardiovalve Transfemoral Mitral Valve System is a clinical trial registered under NCT03813524. Current status: TERMINATED.
What is the status of NCT03813524?
The current status of NCT03813524 (Cardiovalve Transfemoral Mitral Valve System) is: TERMINATED.
When did Cardiovalve Transfemoral Mitral Valve System start?
Cardiovalve Transfemoral Mitral Valve System started on 2019-03-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.